la sec te lleva a esc21 [in] ∙ loop study
Published 2 years ago • 606 plays • Length 5:32Download video MP4
Download video MP3
Similar videos
-
![la sec te lleva a esc21 [in] ∙ ssass study](https://i.ytimg.com/vi/6g1Lh57o7Is/mqdefault.jpg)
5:46
la sec te lleva a esc21 [in] ∙ ssass study
-
![la sec te lleva a esc21 [in] ∙ 2021 esc guidelines on cardiac pacing (ii)](https://i.ytimg.com/vi/9mEXOtdwPyY/mqdefault.jpg)
7:35
la sec te lleva a esc21 [in] ∙ 2021 esc guidelines on cardiac pacing (ii)
-
![la sec te lleva a esc21 [in] ∙ 2021 esc guidelines on cardiac pacing (i)](https://i.ytimg.com/vi/8Mb_GWyx3eE/mqdefault.jpg)
9:52
la sec te lleva a esc21 [in] ∙ 2021 esc guidelines on cardiac pacing (i)
-
![la sec te lleva a esc21 [in] ∙ decaaf ii](https://i.ytimg.com/vi/zBJXHqklDD4/mqdefault.jpg)
7:00
la sec te lleva a esc21 [in] ∙ decaaf ii
-
![la sec te lleva a esc22 [in] - all-heart](https://i.ytimg.com/vi/bK_ynmtbwb4/mqdefault.jpg)
4:02
la sec te lleva a esc22 [in] - all-heart
-
30:04
the new esc guidelines on valvular heart disease, prof. bernard prendergast
-
![la sec te lleva a esc22 [in] - guías de hipertensión pulmonar](https://i.ytimg.com/vi/VXWf-hKMoZo/mqdefault.jpg)
10:23
la sec te lleva a esc22 [in] - guías de hipertensión pulmonar
-
![la sec te lleva a esc21 [in] ∙ pronounce](https://i.ytimg.com/vi/pM-rV5J1-hM/mqdefault.jpg)
5:52
la sec te lleva a esc21 [in] ∙ pronounce
-
![la sec te lleva a esc21 [in] ∙ fidelity analysis](https://i.ytimg.com/vi/oLxE7l_qXRM/mqdefault.jpg)
5:33
la sec te lleva a esc21 [in] ∙ fidelity analysis
-
![la sec te lleva a esc21 [in] ∙ guide-hf trial](https://i.ytimg.com/vi/dTSfsOIl0bA/mqdefault.jpg)
5:48
la sec te lleva a esc21 [in] ∙ guide-hf trial
-
![la sec te lleva a esc21 [in] ∙ esc/eacts guidelines for the management of valvular heart disease (i)](https://i.ytimg.com/vi/48pTGvqiE4Q/mqdefault.jpg)
7:51
la sec te lleva a esc21 [in] ∙ esc/eacts guidelines for the management of valvular heart disease (i)
-
![la sec te lleva a esc21 [in] ∙ avanti: dual vp-receptor antagonism in hf](https://i.ytimg.com/vi/22Zx5j7DWuk/mqdefault.jpg)
6:18
la sec te lleva a esc21 [in] ∙ avanti: dual vp-receptor antagonism in hf
-
![la sec te lleva a esc21 [in] ∙ smart-mi-icms trial](https://i.ytimg.com/vi/WUSFjfOxhs4/mqdefault.jpg)
5:23
la sec te lleva a esc21 [in] ∙ smart-mi-icms trial
-
![la sec te lleva a esc21 [in] ∙ analysis of the master-dapt trial](https://i.ytimg.com/vi/lk4_f9-YnEQ/mqdefault.jpg)
6:50
la sec te lleva a esc21 [in] ∙ analysis of the master-dapt trial
-
![la sec te lleva a esc21 [in] ∙esc/eacts guidelines for the management of valvular heart disease (ii)](https://i.ytimg.com/vi/pFBOFQaS16E/mqdefault.jpg)
5:46
la sec te lleva a esc21 [in] ∙esc/eacts guidelines for the management of valvular heart disease (ii)
-
![la sec te lleva a acc20 [in] ∙ maverick hcm study](https://i.ytimg.com/vi/BXt4IUg8QIc/mqdefault.jpg)
6:13
la sec te lleva a acc20 [in] ∙ maverick hcm study
-
![la sec te lleva a acc19 [in] ∙ the apple heart study](https://i.ytimg.com/vi/E5pX5an3jq0/mqdefault.jpg)
9:05
la sec te lleva a acc19 [in] ∙ the apple heart study
-
![la sec te lleva a esc22 [in] - invictus trial](https://i.ytimg.com/vi/6OdBHLGNjEQ/mqdefault.jpg)
6:01
la sec te lleva a esc22 [in] - invictus trial